首页> 外文期刊>The Open Conference Proceedings Journal >New Perspective in Pain Treatment
【24h】

New Perspective in Pain Treatment

机译:疼痛治疗的新观点

获取原文
           

摘要

Pain is a disabling condition with a remarkable clinical relevance. Nevertheless the neuronal basis of its transmission and modulation are not completely known. So, the neurochemical characterisation of the nociceptive pathway plays a pivotal role to develop new analgesic strategies. Several factors and chemicals are involved in the activation of the nociceptive pathway both in peripheral (PNS) and central (CNS) nervous system. Recently, a number of researches focus on the role of cannabinergic, purinergic, glutamatergic and nitroxidergic systems in pain transmission showing that new drugs interfering with these systems could be useful for pain treatment. In addition, other molecules, such antioxidants and aquaporins, which are not classified as chemicaleurochemical mediators, can be altered during pain processing and interfere with nociceptive trasmission. Moreover, there is an increased evidence that activated glia and nerve growth factor (NGF) could be involved in the induction and maintenance of pain. Finally, stem cell transplantation shows potential therapeutic effects in neuropathic pain conditions. In this paper the recent results about new molecules acting on cannabinergic, purinergic, glutamatergic and nitroxidergic systems, NGF and stem cell transplantation involvement in pain treatment, will be discussed.
机译:疼痛是一种具有重大临床意义的致残性疾病。然而,其传递和调节的神经元基础尚不完全清楚。因此,伤害性途径的神经化学表征在开发新的镇痛策略中起着关键作用。周围神经系统(PNS)和中枢神经系统(CNS)的伤害感受途径的激活均涉及多种因素和化学物质。近来,许多研究集中于大麻素能,嘌呤能,谷氨酸能和氮氧化能系统在疼痛传播中的作用,表明干扰这些系统的新药可用于疼痛治疗。另外,未分类为化学/神经化学介质的其他分子,例如抗氧化剂和水通道蛋白,可在疼痛过程中发生改变并干扰伤害性传递。此外,越来越多的证据表明,活化的神经胶质和神经生长因子(NGF)可能与疼痛的诱导和维持有关。最后,干细胞移植在神经性疼痛中显示出潜在的治疗作用。在本文中,将讨论有关新分子作用于大麻素,嘌呤能,谷氨酸能和一氧化氮能系统,NGF和干细胞移植参与疼痛治疗的最新结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号